Compare FIEE & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FIEE | TELA |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | 43 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 37.5M |
| IPO Year | N/A | 2019 |
| Metric | FIEE | TELA |
|---|---|---|
| Price | $7.00 | $0.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 18.2K | ★ 103.7K |
| Earning Date | N/A | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.59 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $80,275,000.00 |
| Revenue This Year | N/A | $17.75 |
| Revenue Next Year | N/A | $16.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.84 |
| 52 Week Low | $1.50 | $0.62 |
| 52 Week High | $7.95 | $2.19 |
| Indicator | FIEE | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 39.23 |
| Support Level | $6.60 | N/A |
| Resistance Level | $7.26 | $1.22 |
| Average True Range (ATR) | 0.34 | 0.10 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 27.02 | 22.59 |
FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.